Ampio Pharma (AMPE) Reports In-Line Q2 EPS

Ampio Pharma (NYSE: AMPE) reported Q2 EPS of ($0.02), in-line with the analyst estimate of ($0.02).

For earnings history and earnings-related data on Ampio Pharma (AMPE) click here.

You May Also Be Interested In

• Growth isn't weak enough to truly undercut inflation pressures - BMO
• American Express (AXP) down despite beating Q1 estimates on top and bottom lines
• MetroCity Bankshares, Inc. (MCBS) Tops Q1 EPS by 4c